Whether Canafenib/Encofenib (Betavir) needs to be taken for a long time and drug safety analysis
Canafenib/Encorafenib (Encorafenib) is a BRAF inhibitor, mainly used to treat patients with BRAF V600E or V600K mutated melanoma and some colorectal cancer patients. In clinical practice, the use of this drug usually requires long-term maintenance to maximize the inhibition of tumor progression. Since the mechanism of action of this type of targeted drugs is to continuously inhibit abnormal signaling pathways, tumors may relapse or progress rapidly after stopping the drug, so most patients need to continue taking them under the guidance of a doctor.
During long-term medication, canafenib is often used in combination with other drugs (such as the MEK inhibitor trametinib) to improve efficacy and delay the emergence of drug resistance. The safety of long-term medication has been verified in multiple clinical studies, but patients also need to pay close attention to adverse reactions. Common side effects include rash, photosensitivity, joint pain, fatigue, and high blood pressure. Some patients may experience more serious adverse reactions and require timely intervention or dose adjustment.

Medication safety analysis shows that most of the adverse reactions of canafenib are manageable, and the risk can be effectively reduced through regular review and doctor's monitoring. For example, regular liver function, blood pressure and skin tests can help detect potential problems early. In addition, patients should pay attention to sun protection, maintain a healthy diet, and avoid taking ingredients with potential drug interactions in daily life to reduce the risk of adverse reactions.
In general, canafenib, as a targeted drug, usually needs to be taken long-term to maintain its efficacy. Standardized management and follow-up monitoring under the guidance of doctors can help patients prolong their survival time and improve their quality of life. Patients should strictly follow the doctor's instructions and never stop taking the medication or adjust the dosage on their own to ensure the effectiveness and safety of the treatment.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)